Last reviewed · How we verify
Phase 4 Study to Evaluate Efficacy And Safety of Three Different Preparations of Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma (LATANOPROST)
This study examines efficacy and tolerability of 3 different Latanoprost 0.005% eyedrops preparations, commercially available in Italy, in subjects affected by primary open angle glaucoma.
Details
| Lead sponsor | University of Catanzaro |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 120 |
| Start date | 2011-06 |
| Completion | 2012-07 |
Conditions
- Intraocular Pressure (IOP)
- Tear Break-Up Time
Interventions
- IOPIZE© Latanoprost eyedrops
- GALAXIA© Latanoprost eyedrops
- Latanoprost RATIOPHARM© latanoprost eyedrops
Primary outcomes
- intraocular pressure (IOP) in mmHg — one month - two months
to evaluate intraocular pressure (IOP) reduction after one and two months treatment with latanoprost eyedrops
Countries
Italy